Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study

References

• Lip GYH, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation. Chest. 2018;154(5):1121–1201. doi:10.1016/j.chest.2018.07.04030144419
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease. Chest. 2016;149(2):315–352. doi:10.1016/j.chest.2015.11.02626867832
   PubMed Web of Science ®Google Scholar
• Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095–1106. doi:10.1001/archinte.165.10.109515911722
   PubMed Web of Science ®Google Scholar
• Wadelius M, Chen LY, Eriksson N, et al. Association of warfarin dose with genes involved in its action and metabolism. Hum Genet. 2007;121(1):23–34. doi:10.1007/s00439-006-0260-817048007
   PubMed Web of Science ®Google Scholar
• Czuprynska J, Patel JP, Arya R. Current challenges and future prospects in oral anticoagulant therapy. Br J Haematol. 2017;178(6):838–851. doi:10.1111/bjh.1471428573648
   PubMed Web of Science ®Google Scholar
• Baglin T. Clinical use of new oral anticoagulant drugs: dabigatran and rivaroxaban. Br J Haematol. 2013;163(2):160–167. doi:10.1111/bjh.1250223937286
   PubMed Web of Science ®Google Scholar
• Ware JE Jr., Sherbourne CD, The MOS. 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.1593914
   PubMed Web of Science ®Google Scholar
• Keita I, Aubin-Auger I, Lalanne C, et al. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism. Patient Prefer Adherence. 2017;11:1625–1634. doi:10.2147/PPA.S13115729026288
   PubMed Web of Science ®Google Scholar
• Wang Y, Kong MC, Lee LH, Ng HJ, Ko Y. Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control. Thromb Res. 2014;133(4):550–554. doi:10.1016/j.thromres.2014.01.00224448058
   PubMed Web of Science ®Google Scholar
• Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M. Issues in the measurement of satisfaction with treatment. Am J Manag Care. 1997;3(4):579–594.10169526
   PubMed Web of Science ®Google Scholar
• Kravitz RL. Patients’ expectations for medical care: an expanded formulation based on review of the literature. Med Care Res Rev. 1996;53(1):3–27. doi:10.1177/10775587960530010110156434
   PubMed Web of Science ®Google Scholar
• Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236–239.8470047
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Pogue J, Eikelboom J, et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118(20):2029–2037. doi:10.1161/CIRCULATIONAHA.107.75000018955670
   PubMed Web of Science ®Google Scholar
• Fong DYT, Lam CLK, Mak KK, et al. The short form-12 health survey was a valid instrument in Chinese adolescents. J Clin Epidemiol. 2010;63(9):1020–1029. doi:10.1016/j.jclinepi.2009.11.01120189764
   PubMed Web of Science ®Google Scholar
• Mohamed S, Razak TA, Hashim R. Translation, validation and psychometric properties of Bahasa Malaysia version of the Perception of Anticoagulant Therapy Questionnaire (PACTQ). Asian Journal of Biomedical and Pharmaceutical Sciences. 2015;5(48):18–22.
   Google Scholar
• Noor NM, Aziz AA. Validity and reliability of the malay version of 12-item short form health survey among postpartum mothers. Malaysian J Public Health Med. 2014;14:1–11.
   Google Scholar
• Prins MH, Marrel A, Carita P, et al. Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the ‘Perception of Anticoagulant Treatment Questionnaire’ (PACT-Q). Health Qual Life Outcomes. 2009;7:9. doi:10.1186/1477-7525-7-919196486
   PubMed Web of Science ®Google Scholar
• Prins MH, Guillemin I, Gilet H, et al. Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q). Health Qual Life Outcomes. 2009;7:30. doi:10.1186/1477-7525-7-3019348685
   PubMed Web of Science ®Google Scholar
• Benzimra M, Bonnamour B, Duracinsky M, et al. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation. Patient Prefer Adherence. 2018;12:79–87. doi:10.2147/PPA.S13115829379275
   PubMed Web of Science ®Google Scholar
• Stampfuss J, Kubitza D, Becka M, Mueck W. The effect of food on the absorption and pharmacokinetics of rivaroxaban. Int J Clin Pharmacol Ther. 2013;51(7):549–561. doi:10.5414/CP20181223458226
   PubMed Web of Science ®Google Scholar
• Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694. doi:10.1111/j.1538-7836.2005.01204.x15842354
   PubMed Web of Science ®Google Scholar
• Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119–2126.26764429
   PubMed Web of Science ®Google Scholar
• Monz BU, Connolly SJ, Korhonen M, Noack H, Pooley J. Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study. Int J Cardiol. 2013;168(3):2540–2547. doi:10.1016/j.ijcard.2013.03.05923664436
   PubMed Web of Science ®Google Scholar
• Contreras Muruaga MDM, Vivancos J, Reig G, et al. Satisfaction, quality of life and perception of patients regarding burdens and benefits of vitamin K antagonists compared with direct oral anticoagulants in patients with nonvalvular atrial fibrillation. J Comp Eff Res. 2017;6(4):303–312. doi:10.2217/cer-2016-007828353372
   PubMed Web of Science ®Google Scholar
• Alegret JM, Vinolas X, Arias MA, et al. New oral anticoagulants vs vitamin K antagonists: benefits for health-related quality of life in patients with atrial fibrillation. Int J Med Sci. 2014;11(7):680–684. doi:10.7150/ijms.891624843316
   PubMed Web of Science ®Google Scholar
• Marvig CL, Verhoef TI, de Boer A, et al. Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants. Thromb Res. 2015;136(1):69–75. doi:10.1016/j.thromres.2015.04.02625956287
   PubMed Web of Science ®Google Scholar
• Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med. 1991;151(10):1944–1949.1929681
   PubMedGoogle Scholar
• Balci KG, Balci MM, Canpolat U, et al. Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation. Anatolian J Cardiol. 2016;16(7):474–481. doi:10.5152/AnatolJCardiol.2015.6334
   Web of Science ®Google Scholar
• Prins MH, Bamber L, Cano SJ, et al. Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial. Thromb Res. 2015;135(2):281–288. doi:10.1016/j.thromres.2014.11.00825483215
   PubMed Web of Science ®Google Scholar
• Cano S, Mantovani L, Folkerts K, et al. Patient-reported treatment experience with oral rivaroxaban: results from the noninterventional XALIA study of deep-vein thrombosis. TH Open. 2018;02(02):e139–e146. doi:10.1055/s-0038-1641679
   Google Scholar
• Willich SN, Bauersachs R, Gitt AK, et al. Treatment satisfaction in patients with venous thromboembolism as measured with pact-Q2: prefer in vte registry. Value Health. 2014;17(7):A496–A497. doi:10.1016/j.jval.2014.08.1483
   Web of Science ®Google Scholar
• Almeida Gde Q, Noblat Lde A, Passos LC, Do Nascimento HF. Quality of life analysis of patients in chronic use of oral anticoagulant: an observational study. Health Qual Life Outcomes. 2011;9:91. doi:10.1186/1477-7525-9-4022027368
   PubMed Web of Science ®Google Scholar
• Gadisseur AP, Kaptein AA, Breukink-Engbers WG, van der Meer FJ, Rosendaal FR. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. J Thromb Haemost. 2004;2(4):584–591. doi:10.1111/j.1538-7836.2004.00659.x15102012
   PubMed Web of Science ®Google Scholar
• Casais P, Meschengieser SS, Sanchez-Luceros A, Lazzari MA. Patients’ perceptions regarding oral anticoagulation therapy and its effect on quality of life. Curr Med Res Opin. 2005;21(7):1085–1090. doi:10.1185/030079905X5062416004677
   PubMed Web of Science ®Google Scholar